Commense is a Boston-based company that focuses on developing microbiome-derived therapeutics to prevent and treat diseases in infants and children. By leveraging natural exposures to beneficial microbes, Commense aims to guide the development and maintenance of the microbiome early in life, promoting a lifetime of good health. Their innovative approach addresses critical unmet needs in pediatric populations and aims to protect babies born via C-section from the future onset of serious conditions. Working with leading microbiome scientists, physicians, and product developers, Commense is pioneering a new category of products that harness the power of the microbiome to improve health outcomes in early childhood.